Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study Into the Performance of the KeyPathtm MRSA/MSSA Blood Culture Test - BTA

NCT01640886 is registered in ClinicalTrials.gov with MicroPhage, Inc. as lead sponsor.

NCT NCT01640886
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01640886 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study Into the Performance of the KeyPathtm MRSA/MSSA Blood Culture Test - BTA
Lead sponsor
MicroPhage, Inc.
Phase
Observational
Overall status
Terminated
Start date
June 30, 2012
Completion date
December 31, 2012
Enrollment
764 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia